Skip to content

Acute versus chronic inflammation: analysis of the T-cell function in the tonsilla palatina as surrogate marker of the immune status with patients with peritonsillar abscess versus patients with chronic tonsillitis

Acute versus chronic inflammation: analysis of the T-cell function in the tonsilla palatina as surrogate marker of the immune status with patients with peritonsillar abscess versus patients with chronic tonsillitis - HTTS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00007801
Enrollment
21
Registered
2015-02-27
Start date
2014-01-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J36 J35.0 J35.1

Interventions

Group 1: Patient with peritonsillar abscess and emergent tonsillectomy
taking of tissue samples of palatine tonsils Group 2: Patients with chronic tonsillitis and scheduled resection of palatine tonsils
taking of tissue samples of palatine tonsils Group 3: Patients with rhonchopathy due to tonsil hypertrophy and scheduled resection of palatine tonsils
taking of tissue samples of palatine tonsils

Sponsors

Integriertes Forschungs- und Behandlungszentrum Sepsis und SepsisfolgenKlinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patient groups: 1. male or female patients, age at least 18 years 2. written informed consent Only patient group A: patients with peritonsillar abscess and emergent tonsillectomy Only patient group B: patients with chronic tonsillitis (with 3 or more episodes of recidival acute tonsillitides per year) and scheduled for routine tonsillectomy Only patient group C: patients without acute or chronic tonsillitis, but scheduled for routine tonsilectomy due to rhonchopathy or obstructive sleep apnea syndrome

Exclusion criteria

Exclusion criteria: 1. therapy with steroids or other immunosuppressive therapy 2. severe chronic diseases in medical history 3. Therapy with coagulation inhibitors or abnormally low coagulation status

Design outcomes

Primary

MeasureTime frame
Difference in the T cell response of patients with peritonsillar abscess, chronic tonsillitis and tonsil hyperplasia regarding activation, proliferation and apoptosis and thereby investigate the existence of T cell specific parameters to systemic and local inflammation

Secondary

MeasureTime frame
Investigation of the use of the tonsils, as an easily available secondary lymphoid organ, for the determination of the immune status of patients with severe local inflammatory reaction to sepsis

Countries

Germany

Contacts

Public ContactOrlando Guntinas-Lichius

Integriertes Forschungs- und BehandlungszentrumSepsis und SepsisfolgenKlinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde

orlando.guntinas@med.uni-jena.de03641-9-35127

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026